SURPASS-CVOT Research into new drug (tirzepatide) for type 2 diabetes and heart disease, compared to dulaglutide. Read More Active StudiesCharlie FranklinDecember 18, 2020Tirzepatide, GLP-1 RA, Metformin, Ozempic, Dulaglutide, CVOT